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I. INTRODUCTION: 
Peripheral arterial occlusive disease or PAOD has been found to have a prevalence of 12 to 
20% in individuals over 65 years of age (1). The prevalence of PAOD in patients older than 
55 years was found to be around 20 per cent (1). Cross-sectional diagnostic imaging can 
determine severity and location of stenosis and is therefore indispensable for planning of 
interventional and surgical procedures. Conventional intra-arterial angiography or digital 
subtraction angiography, the gold-standard for assessment of peripheral arterial disease is 
associated with the risks of an invasive technique, ionising radiation, and nephrotoxic 
iodinated contrast media and hospitalisation costs. 
CT Angiography (CTA) gives high spatial resolution images, without the risks of an 
invasive procedure.  The risk of iodinated contrast related nephropathy and ionizing 
radiation are the drawbacks of contrast-enhanced CT Angiography (2).  
3-D contrast enhanced MR Angiography has been proven to have a high diagnostic accuracy 
in the assessment of peripheral arterial disease(3). This is however associated with adverse 
effects of contrast particularly nephrogenic systemic fibrosis in patients with renal 
dysfunction.  
As the patients with peripheral arterial occlusive disease are also at an increased risk of renal 
involvement, the use of iodinated contrast for CT Angiography is of particular concern.  
Patients with impaired renal function are also at a higher risk for development of nephrogenic 
systemic fibrosis with Gadolinium containing contrast media. 
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This led to the introduction of non- contrast MR Angiography, which can safely be used in 
patients with renal failure also. Initial non-contrast MR Angiography techniques (viz. time of 
flight and phase contrast) were associated with drawbacks such as lengthy acquisition times 
and overestimation of the degree of stenosis.  
Non contrast MR Angiography with ECG triggered balanced steady state free precession 
(bSSFP) has evolved as a newer technique for the imaging of peripheral arterial occlusive 
disease, which overcomes the above limitations. Limited studies are available on this newer 
technique of non-contrast MR Angiography in patients with PAOD. 
 
This study is aimed at evaluating the efficacy of ECG triggered balanced steady state free 
precession (bSSFP), a novel technique of non-contrast MR Angiography and 2-D TOF 
(Time-of-flight), which is a flow compensated gradient echo sequence, for the evaluation of 
peripheral arterial disease of lower limbs.  
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II. AIMS AND OBJECTIVES: 
 
A) AIM:  
The aim of this study was to assess the diagnostic performance of ECG-gated non-
contrast-enhanced b-SSSP (balanced steady state free precision) Magnetic Resonance 
Angiography at a magnetic field strength of 1.5 Tesla in patients with peripheral 
arterial occlusive disease. 
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B) OBJECTIVES: 
1) To compare the diagnostic efficacy of non-contrast MR  
Angiography with contrast MR Angiography and Computed Tomography (CT) 
Angiography in patients with PAOD, in terms of the quantitative assessment of 
the degree of stenosis and the quality of the images obtained.  
2) To assess the inter-observer variability in the evaluation of the degree of 
stenosis and the quality of the images obtained. 
3) To compare with other non-invasive imaging modalities in cases of 
discrepancies. 
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III. LITERATURE REVIEW: 
PERIPHERAL ARTERIAL OCCLUSIVE DISEASE(PAOD): 
 
Peripheral arterial occlusive disease involving the lower limbs is a common cause of 
impaired ambulation and is one of the leading causes of extremity wounds and 
amputations. In patients older than 55 years, the prevalence of PAOD was found to be 
around 20 per cent(1). Worldwide, in high-income countries, the estimated prevalence 
ranged from 5.3 per cent to 18.5 per cent (for those between 45 to 49 years of age and 
for those between 85 to 89 years of age, respectively) (4). 
 
There is a significant association with atherosclerosis in other sites in the body, thus 
rendering the affected vulnerable to the risk of cardiovascular and cerebrovascular 
events, morbidity and mortality. 
Peripheral arterial disease may occur due to different causes, which includes 
atherosclerosis (being the most common cause in the elderly population) and 
thrombangitis obliterans (seen in young smokers). 
Patients with peripheral arterial disease predominantly have involvement of the lower 
limbs. 
 
A. EPIDEMIOLOGY AND RISK FACTORS OF PAOD: 
The risk factors for peripheral arterial disease are very similar to the risk factors which 
cause coronary atherosclerosis.   
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The patients with following features were found to have a higher prevalence of 
peripheral arterial disease as identified by the American College of Cardiology, 
American Heart Association (ACC/AHA) (5): 
- a history of smoking or diabetes, age 50 to 69 years  
- age ≥70 years 
- diabetes and at least one other risk factor for atherosclerosis in an age group of 
40 to 49 years 
- abnormal lower extremity pulse on examination 
- symptoms suggestive of claudication pain with exertion, or ischemic pain at 
rest  
- known atherosclerosis at other sites (e.g., renal artery disease, coronary, 
carotid involvement). 
Some of the other risk factors include: 
- male gender 
- black ethnicity 
- family history of atherosclerosis 
- smoking, hypertension, hyperlipidemia, and homocysteinemia. 
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B. CLINICAL FEATURES OF PAOD: 
The following clinical presentation of peripheral arterial occlusive disease was 
suggested by the 2005 (ACC/AHA) guidelines in patients ≥50 years of age (3,4): 
●20 to 50 % - asymptomatic    
●40 to 50 % - atypical leg pain   
●10 to 35 % - classic claudication   
●1 to 2 % - threatened limb  
 a) Asymptomatic: Identifying asymptomatic patients with peripheral arterial     
occlusive disease is of importance as these patients are also at higher risk for 
atherosclerosis in other sites and may benefit from medical treatment, which then 
subsequently lowers their risk for stroke, myocardial infarction and death.  
b) Atypical lower extremity pain and intermittent claudication: They may present 
with intermittent claudication or atypical pain in the lower extremities, which may 
develop due to inadequate blood supply of the muscles or even due to a mismatch 
between the blood supply and the demand. In a study by Hirsch et.al, (7) among cases 
of newly diagnosed PAOD, around 47 per cent of the cases had no history of leg 
symptoms, only 6 per cent had classic claudication and 47 per cent had atypical leg 
symptoms. Among those with prior PAOD, approximately 25 per cent had no leg 
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symptoms, 14 per cent had classic claudication and 61 per cent had atypical leg 
symptoms. 
c) Threatened limb: Patients with PAOD can present initially with a threatened limb 
(critical limb ischemia). It has been found that among patients who are more than 50 
years of age, 1 to 2 per cent of patients with PAOD present in this manner (5,6). 
1. SYMPTOMS (of peripheral arterial occlusive disease) :   
i. Pain in the lower extremity  
a) Claudication: classic intermittent claudication is induced by exercise and 
relieved by rest. It can present as buttock and hip or thigh or calf or foot 
claudication.  
b) Atypical pain in the extremity 
c) Ischemic rest pain 
d) Severe diffuse pain 
ii. Non-healing wound/ ulcer 
iii. Skin discolouration / gangrene 
2. EXAMINATION FINDINGS: 
i. Skin colour: will vary depending on the perfusion of the tissues, where normal 
skin will remain pink even on elevation. In patients with symptomatic disease, 
the skin will appear rubrous or cyanotic. 
ii. Ulceration: the ulcers are often painful, dry and punched out. 
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iii. Gangrene: dry gangrene is common in patients with peripheral arterial disease. 
iv. Pulses: absent pulses/ feeble pulses are seen in the involved arterial segments. 
When limb ischemia presents as sudden decrease in limb perfusion, within two weeks 
of the inciting event, this is defined as acute ischemia, according to the 2007 Inter-
Society Consensus for the Management of Peripheral Arterial Disease (TASC II) (8). 
When the symptoms occur for more than two weeks it is considered to be chronic 
ischemia. 
C. DIAGNOSIS OF PERIPHERAL ARTERIAL OCCLUSIVE 
DISEASE: 
Typical history of peripheral arterial disease and risk factors for PAOD may be 
adequate to diagnose this condition in some of the patients. 
In asymptomatic patients, clinical examination (e.g., skin temperature and peripheral 
pulses) alone has a poor sensitivity in diagnosing PAOD (9).  
In patients with atypical pain, or pulses which may be equivocal on examination, an 
ankle-brachial pressure index serves as a diagnostic parameter. 
The ankle-brachial index pressure (ABPI) serves as a simple, inexpensive and 
accurate test in screening for PAOD. This done by assessing the ratio of systolic 
pressures in the lower extremities versus upper extremities (10). ABPI cut-off of less 
than 0.9 has been reported to have a sensitivity ranging from 79 to 95 per cent with 
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specificity consistently more than 95 per cent in patients with high clinical suspicion 
of PAOD (6). 
In detecting significant PAOD, ABPI, as compared to angiography, has excellent 
overall accuracy(stenosis ≥50 per cent) (area under ROC curve = 0.95) (11). 
An ABPI between 0.90–1.0 is considered borderline. In calcified atherosclerosis, there 
may be a falsely elevated ABPI (often > 1.3), due to the arteries may becoming stiff 
and non-compressible. 
The rationale behind screening patients with peripheral arterial disease is for the sake 
of early intervention, in order to prevent progression of peripheral arterial disease and 
also to recognise those individuals at high risk of coronary heart disease and 
cardiovascular disease. 
For confirming the diagnosis of PAOD, or in case of uncertainty, and for determining 
the degree of stenosis prior to revascularization, imaging is required. 
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D. NON- INVASIVE DIAGNOSTIC TESTS FOR PAOD: 
1) Duplex ultrasonography:  
This inexpensive and safe imaging modality uses, grey scale (B-mode) and colour 
wave Doppler techniques (8). 
The ratio of PSV between the adjacent normal vessel and the site of stenosis and the 
intra-arterial peak systolic velocity (PSV) are used to assess the degree of stenosis. 
- A stenosis of 50–74% is implied by a PSV ratio of >2.5 and tighter stenosis 
(75–99%) is diagnosed by an end-diastolic velocity is >60 cm/s (12).  
- A PSV ratio >2.0, plus peak systolic velocity >200 cm/s, and/or spectral 
broadening and aliasing is more commonly used to diagnose a stenosis >50% 
(6). 
- The absence of colour flow implies complete arterial occlusion. 
 
In a meta-analysis of 16 studies, duplex USG was found to have a sensitivity of (86%) 
for aorto-iliac lesions  and 80% for femoro-popliteal lesions, with  a 96% or greater 
specificity for both (13). Duplex USG study is however limited by the patient’s body 
habitus, specifically in the evaluation of aorto-iliac arteries, due to intestinal gas and 
abdominal girth. The modality is also user dependent, with varying performance based 
on the user’s experience. 
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2) Computed Tomography Angiography (CTA): 
Multi-detector row CT (MDCT) has made it possible to image the peripheral arteries 
through a single contrast injection and single acquisition. With the advent of the 64-
detector rows and more, visualization of smaller, distal arteries are optimized by a 
minimum (0.4 – 0.6 mm) voxel dimension.  
Newer advanced techniques of post processing of images (including arterial tree) and 
volume rendered (VR) 3-D reconstruction allow better image interpretation and 
analysis of pathology. 
Images similar to traditional angiography rendered by Maximum intensity projection 
(MIP) provides better assessment of the quality of the stenosis. However, bones may 
obscure the usefulness of both MIP and VR images. Bone removal can rectify this by 
software techniques, though some amount of manual correction may still be required.  
Curved planar reformations (CPR) provide better quantitative measurements. There 
may be overestimation of stenosis in vessels with dense calcifications due to the high 
attenuation of calcium leading to blooming artefact (14). 
 
In the evaluation of calcified vessels, post processing after dual-energy CTA, which 
subtracts calcium containing voxels in the vessel wall, is a novel and promising 
technique. CTA requires the use of iodinated contrast media (CM) for visualization of 
the vasculature. 
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Contrast (approximately 100-200 ml for abdominal CTA), is intravenously injected at 
the rate of 4 to 6 cc/s, by a dual channel power injector, and followed by a saline 
chaser (15). 
In the detection of more than 50% stenosis or occlusion, in a recent meta-analysis,  the 
sensitivity of CTA, with DSA as gold standard,  was found to be 95% (95% 
confidence interval [CI], 92%-97%) and specificity was found to be 96% (95% CI, 
93%-97%) (16).  
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3) Magnetic Resonance Angiography: 
It provides an accurate, non-invasive and comprehensive whole body vascular 
evaluation, without the use of ionizing radiation (17). Striking angiographic images 
are feasible in today’s times with high performance MR scanners, which avoid 
radiation exposure and the complexity of removing overlying bone from 3D 
reconstructed images.  
 
MRA can be performed via a contrast-enhanced (CE-MRA) or a non-contrast 
enhanced approach, which utilise the differences in signal properties between static 
tissue and flowing blood through flow-sensitive techniques. 
 
MR Angiography techniques can be broadly classified into: 
1) Flow dependent Angiography: It utilises the fact that surrounding tissue is 
static while blood is flowing. This can be further classified into Time of Flight 
(TOF)/ inflow angiography and Phase contrast MR Angiography. These 
techniques have been described in detail below.  
 
2) Flow independent Angiography: This technique does not rely on the flow of 
blood; instead it is based on the T1 and T2 differences and the chemical shift of 
the different tissues in the voxel. By this technique even areas of slow flow can 
be imaged easily. This includes namely, contrast-enhanced MR Angiography 
and subtractionless contrast – enhanced MR Angiography. 
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Contrast-enhanced MR Angiography- Images are acquired by subtraction of the post 
contrast image from the pre contrast image, which highlights only the blood vessels. 
An alternative blood pool agent (albumin-binding/ polymeric gadolinium complexes) 
may be used instead of Gadolinium based contrast, as blood pool agents remain in the 
blood for an hour, with resultant higher resolution of images. Contrast MR 
Angiography is further discussed in detail subsequently. 
Subtractionless contrast – enhanced MR Angiography- As the name suggests, in this 
technique there is no subtraction of a non-contrast enhanced image. However this 
technique requires excellent fat suppression, which can be achieved using mDIXON 
(modified DIXON) acquisition methods. . 
 
By suppression of fat adjacent to vessels, image contrast between the vessels and soft 
tissues is increased. Using spectrally selective RF pulses, fat signal cannot be properly 
suppressed due to magnetic field inhomogeneities. Modified Dixon technique 
however, can separate fat signal as it is less susceptible to field inhomogeneities.  
  
Another way of classifying MR Angiography is: 
A. Contrast enhanced MR Angiography 
B. Non contrast enhanced MR Angiography 
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A. Contrast-enhanced (CE-MRA): 
This is the primary workhorse of clinical MR Angiography. After the administration 
of intravenous gadolinium (Gd) based (paramagnetic) contrast agents, there is an 
increase in the arterial signal, which occurs due to the shortening of T1 relaxation in 
blood.  
Along with an intravenous bolus injection, fast T1-weighted gradient echo sequences 
with low flip angles are used, providing rapid acquisition of 3D volumes, which have 
high signal to noise ratio (SNR), of vessel to the background. MIP images are then 
generated and these are primarily used for MRA interpretation. 
A dynamic technique is used as it prevents enhancement of the background tissue and 
venous enhancement(18).  
 
Aorta and the peripheral runoff arteries are imaged using a bolus-chase technique in 
multi-station MRA, usually using a bolus of around 0.2 mmol/kg body weight and the 
aortoiliac, femoropopliteal and tibial regions are imaged sequentially. 
Breath hold technique is used for the prevention of motion related artefacts. 
In a recent meta-analysis of  contrast enhanced MRA, studied with DSA as gold 
standard, the pooled sensitivity was found to be 94.7% (95% CI, 92.1% to 96.4%) and 
the specificity was found to be 95.6% (CI, 94.0% to 96.8%) in the diagnosis of steno-
occlusions(19).  
 
Gd-based contrast agents are paramagnetic in nature and are classified based on cyclic 
or linear structure and ionicity and protein binding(20). 
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Currently there are 7 (FDA) Food and Drug Administration approved agents in the 
United States and two agents in the European Union. 
 
The half-life of Gadolinium based contrast agents, in patients with normal renal 
function is approximately 1.5 hours. 
Gadolinium as identified in 2006, can  a potentially cause  nephrogenic systemic 
fibrosis (NSF)(21). The development of NSF, though rare is associated with all 
Gadolinium-based agents. 
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NEPHROGENIC SYSTEMIC FIBROSIS: 
It is a fibrosing disorder seen only in patients with kidney failure.  
Characteristic features are thickening of the skin of the extremities and trunk and 
marked fibrosis and expansion of the dermis, with associated CD34-positive 
fibrocytes (22)(23). 
 The first cases were noted  during 1997- 2000,  in haemodialysis patients or patients 
with failed renal allografts, who developed severe skin induration which was 
histologically thought to be scleromyxedema (24)(25). 
The number of cases has declined dramatically since initial reports, most certainly due 
to the avoidance of gadolinium-containing agents among at-risk patients [18]. As of 
January 2013, over 400 cases of NSF had been identified and reported to the 
International NSF Registry at Yale University. 
There is no predilection to NSF by gender, race, or age(26)(27), the aetiology of renal 
disease, or the duration of renal failure.  
a) Etiology of NSF: Gadolinium: The first published report that suggested an 
association of gadolinium with NSF appeared in 2006.  
in 1997, the first cases of the severe complication nephrogenic systemic 
fibrosis were reported, and the relationship of this disease to gadolinium was 
reported in 2006(24)(21). 
1. Most of the cases though, are seen involving the linear agents which 
include (Magnevist) Gadopentetate dimeglumine, (Optimark) 
Gadoversetamide and (Omniscan) Gadodiamide. NSF has been reported 
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after the administration of the five most commonly used FDA-approved 
gadolinium-chelates in the United States (Magnevist, OptiMARK, 
ProHance, MultiHance and Omniscan) [39].  
2. GFR:  In patient with chronic kidney disease (N = 79/1393, 5.7%) 
exposed to gadolinium, odds of developing NSF were 27 times greater than 
in control subjects with chronic kidney disease (N = 3/2953, 0.1%) who 
were not exposed to gadolinium, as shown in a recent meta-analysis by 
Agarwal et al.(28)  
b) Course of NSF: Nephrogenic systemic fibrosis has a chronic and unremitting 
course, in most patients (29). In a review of the published literature, 28 per cent 
of patients showed no improvement, 20 per cent had modest improvement, and 
28 per cent of patients succumbed to death (29). A severe form of NSF, with 
development of flexion contractures has been seen in 5 per cent of patients.(27) 
Improvement in or remission of NSF has been described in patients with            
recovered of  renal function (29). 
Less than 40 per cent of patients underwent complete remission following  the 
cessation of dialysis (29). 
 
c) Prevention of NSF: The major preventive measure for nephrogenic systemic 
fibrosis that can be currently recommended to patients with advanced kidney 
failure is the avoidance of Gadolinium. Keeping in mind the possibility of the 
risk of NSF, as per the current recommendation any Gadolinium-based contrast 
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agent is to be avoided in patients, whose  GFR is less than 30 mL/min/1.73m2 
(30). 
United States FDA recommends, in patients with estimated glomerular filtration rate 
(eGFR) <30 mL/min per 1.73 m
2
, receiving dialysis, or with acute kidney injury 
(AKI)(31):  
●Gadolinium-containing contrast agents should be used only if clearly necessary. 
Gadolinium should be avoided in patients with a diagnosis or clinical suspicion of 
NSF. 
●Gadodiamide (Omniscan), gadopentetate-dimeglumine(Magnevist)and 
Gadoversetamide (OptiMARK) should be avoided 
 
d) Treatment of NSF: There is no proven medical therapy for NSF other than 
recovery of renal function (29). 
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B. NON CONTRAST ENHANCED MR ANGIOGRAPHY(NCE-MRA): 
 
Unenhanced MR Angiography may be a better approach for avoiding the potentially 
severe adverse effects associated with contrast agents. All contrast risks are eliminated 
with NCE-MRA techniques and this also be used in patients with difficult intravenous 
access (17). Contraindication of iodinated / gadolinium based IV contrast material is 
another situation where NCE-MRA is preferred. 
Prolonged acquisition times and motion artefacts are the disadvantages of  NCE-
MRA(32). 
NCE-MRA methods, with improvements in MR hardware and software, outweigh  the 
risk concerns of nephrogenic systemic fibrosis due to gadolinium-based contrast in 
patients with vascular or metabolic disorders and moderate to severe renal 
insufficiency (32). 
 
Two original NCE-MRA techniques, time-of-flight and phase-contrast are not widely 
accepted for imaging of peripheral arteries. This is due to two reasons;  the limited 
spatial coverage (or time inefficiency) and well-known flow artefacts, which are 
associated with complex flow(32). 
Fast and robust gradient- echo (GRE) sequences are available, among which one type 
is a steady-state sequence.   
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Non- contrast MR Angiography sequences include: 
1. Time of Flight (TOF) MR Angiography 
2. Phase contrast imaging MR Angiography 
3. ECG- gated FSE (fast spin echo) MR Angiography 
4. SSFP (steady-state free precession) Angiography 
5. ASL ( arterial spin labelling) with SSFP technique 
6. Black blood imaging 
 
 
 
 
1.TIME-OF-FLIGHT MRA (TOF): 
Principle: Time-of-Flight MRA is one of the most commonly used techniques of NCE 
MRA , especially for peripheral and intracranial arterial assessment (32).Background 
signal is suppressed due to saturation of the signal from stationary tissue by rapid 
slice-selective radiofrequency excitation pulses in TOF. Using saturation band on the 
venous side of the imaging slice aids to null the signal and mask the venous flow. The 
incoming blood will be free of the excitation pulse in tissue planes with high flow 
velocity. Hence saturation of the background tissues will lead to strong signal 
intensities in the arteries. Saturation of the blood flow in the image volume and poor 
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vessel visualization will occur due to retrograde filling, tortuous vessels, slow blood 
flow or stasis, or vessels which are in the same plane as the image slice. 
 
In patients with peripheral arterial disease, using a ECG-gated 3D NCE-MRA 
technique, satisfactory image quality demonstrating significant arterial stenosis could 
be achieved without the use of exogenous contrast by Lanzman et al(33). 
It exploits the inflow effect of blood protons and uses flow-compensated 2D or 3D 
gradient-echo sequences(34)(35). 
Unsaturated blood protons flowing into the imaging section or slab have greater signal 
intensities than do the in-plane or in-slab background stationary protons saturated by 
repeated radiofrequency (RF) excitations with a short repetition time (26,28).  
 
Systolic gating is used to enhance the inflow effect and reduce ghost artefacts (26,27). 
 
(Fig.1 Adapted from (36)) 
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The advantages of TOF-MRA are: 
a) The robustness and ease of imaging and interpretation of images are the advantages.  
 
The disadvantages of TOF-MRA are: 
a) Disadvantages are long acquisition time and saturation effect, particularly with 2D 
TOF causing signal loss of in-plane flow and pseudo stenosis in vessels parallel to the 
image plane (26,29).  
b) Overestimation of the severity of stenosis may occur due to signal loss due to 
intravoxel dephasing in vessels with complex or turbulent flow (37). 
Susceptibility artefacts causing large signal loss is another disadvantage (38). 
 
The applications of TOF- MRA are: 
a) Mainstay application of TOF- MRA is for evaluating the intracranial arteries (34). 
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2.PHASE-CONTRAST IMAGING: 
Principle: It is based on the detection of a phase shift caused by blood flowing 
through, in the presence of a magnetic field gradient using bipolar or flow-
compensated pulses (26,27,31).  
The advantages are: 
a) flow direction independent, and 
b) excellent background signal suppression(26,32). 
 
The disadvantages are: 
a) it is a time consuming study, 
b) intravoxel dephasing leading to the loss of signal in vessels with turbulent flow, 
which causes over estimation of stenosis (39). 
c) susceptibility to motion because of the nature of subtraction, and  
d) as the image quality depends on the velocity-encoding factor preselected by the 
user, there may be difficulty in imaging and image interpretation. 
 
The applications of Phase contrast MRA are: 
a) Imaging of cerebral veins,  renal arteries,  peripheral arteries, and portal veins, prior 
to the advent of novel unenhanced MR angiographic techniques(40), 
 
b) It can show flow (41) and quantify flow velocity in vascular diseases such as 
stenosis, arterio-venous malformations and aneurysms (34,35,36).  
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3D hemodynamic flow information for various vascular diseases, such as aneurysm, 
stenosis, wall shear stress, and anomalies, with the aid of visualization tools from cine 
time-resolved 3D phase-contrast imaging technique was more recently developed 
(37,38,39,40).  
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3. ECG-GATED FSE MR ANGIOGRAPHY: 
Principle: This uses the flow void effect of fast arterial flow during systole, described 
under the names FBI (fresh blood imaging), Delta Flow, NATIVE SPACE (sampling 
perfection with use of optimized contrasts using different flip angle evolutions), 
TRANCE (Triggered Angiography Non-contrast-enhanced), and Flow Prep(26,41).  
Images are obtained by subtracting systolic images (where the arteries show flow 
void, as compared to the background tissue, due to fast flow) from diastolic images 
(where the arteries are bright due to slow flow). Bright blood angiography is produced 
by this technique (26,42). 
Reduction of the data sampling duration is useful to produce images with sufficient 
quality, for maximizing the differences in signals between systole and diastole. 
Reduction of  T2-weighted blurring, and motion-related artefacts are achieved by this 
(34). Partial-Fourier techniques such as half-Fourier acquisition single-shot turbo spin 
echo (HASTE), rapid acquisition with relaxation enhancement (RARE), single-shot 
FSE (SSFSE), single-shot turbo spin echo (SSTSE), and fast asymmetric spin echo 
(FASE) and parallel imaging techniques can achieve the above  effect (13,29,30). 
 
To allow sufficient T1 recovery ECG- or pulse wave–gated data are usually acquired 
every two or three heartbeats (R-R intervals). Flow-spoiling gradient pulses are used 
in the readout direction to increase the flow-dephasing effect during systole (34). 
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(Fig.2: Adapted from: (36)) 
 
 
The advantages of ECG- gated FSE MRA are: 
a) Images can be acquired in planes parallel to the vessels. Thus the total image 
acquisition time is shorter than with TOF- MR Angiography. (34) 
b) Display of thin vessels is possible due to high sensitivity of the technique to 
peripheral slow flow (13).  
 
 
The limitations of ECG- gated FSE MRA are: 
a) complexity of imaging and  inadequate image quality due to inappropriate trigger 
timing (34)(45), 
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b) due to differences in flow velocities, there is a possibility of poor detection such as 
in regions distal to a stenosis and in collateral vessels (34), 
c) it is not suitable for patients with arrhythmias because of the nature of subtraction, 
and 
d) ECG-gated FSE Angiography is sensitive to motion (45). 
 
The applications of ECG- gated FSE MRA are:  
a) evaluation of peripheral arteries because of its sensitivity to slow flow (45), 
b) depiction of  thinner vessels such as collaterals and runoff vessels(45), 
c) for stenosis in the calf and pedal arteries, Lim et al reported that ECG-gated FSE 
Angiography has high sensitivity (85.4%), high specificity (75.8%), and high negative 
predictive value (92.3%) although in some cases  severe artefacts were noted (47.2%) 
(45), 
d) its use in the carotid and subclavian arteries is challenging because signals from the 
jugular and subclavian veins remain during systole , 
e) as these arteries are perpendicular to the readout direction the application for renal 
arteries is also difficult, 
f) a more advanced technique, ECG-gated FSE Angiography can be used for 
unenhanced MR DSA by obtaining multiple acquisitions during systole with different 
trigger-time delays(41). This allows us to perform visual hemodynamic evaluation of 
pulse-wave transmission in arteries. 
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4.STEADY-STATE FREE PRECESSION MRA: 
Principle: 
SSFP Angiography, also known as Balanced FFE (fast field echo), True FISP (fast 
imaging with steady-state precession), FIESTA (fast imaging employing steady state 
acquisition), and True SSFP, is a gradient-echo based sequence in which, series of 
equidistant RF pulses  are applied in a steady-state of longitudinal and transverse 
magnetization (40)(41). The image contrast is T2-/T1-weighted, in which high signal 
intensity with little reliance on inflow is given to blood (22, 40, and 41). Angiographic 
images with a high signal-to-noise ratio are produced by using three-dimensional 
acquisition. 
The advantages of SSFP MRA are: 
a) Short acquisition times and high signal-to-noise ratio (41),  
b) Flow-independent 3D acquisition with flow compensated in all three directions (22, 
41, 42). 
The limitations of SSFP MRA are: 
a) its susceptibility to field heterogeneities (33,45) 
b) arteries and veins give high signal intensity due to background signals,  interfering 
with exclusive detection of vessels (34). Hence, additional preparatory pulses, 
including T2 preparation pulses are needed to suppress myocardial and venous signals 
(45) or arterial spin labelling (34) are needed to selectively enhance arteries. 
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The applications of SSFP-MRA are: 
a) It is used for the aorta, particularly with ECG gating in the thoracic aorta. For the 
assessment of thoracic aortic disease, high sensitivity (100%), specificity (100%), and 
diagnostic accuracy (100%) had been reported by Krishnam et al using SSFP 
Angiography with ECG gating.   
b) For renal artery atherosclerosis, fibromuscular dysplasia, and extension of aortic 
dissection to the renal artery, this technique with breath holding or respiratory 
triggering without ECG gating is also used (47) (48) (49). 
c) Furthermore, it is now feasible to perform non- invasive detection of coronary 
artery stenosis with high sensitivity and moderate specificity, which is possible at 1.5-
T  whole-heart coronary MR Angiography with ECG gating (49,50). 
 
Free-breathing ECG-gated SSFP MRA of the thoracic aorta had equal diagnostic 
sensitivity and specificity when compared to CE-MRA as shown  by Krishnam et al. 
in 50 patients who were suspected with thoracic aorta disease (51). 
 
Glockner et al. (52) reported that SSFP provided diagnostic images in a majority of 67 
patients suspected of renal artery stenosis , but found a higher incidence of false 
positive and negative results compared to CE-MRA.  
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In 23 patients undergoing  both CE-MRA and 3D SSFP of the thoracic aorta, François 
et al. (40) showed aortic diameter estimation was essentially equalling both  methods 
with  3D SSFP being superior in visualization of the aortic root. 
 
3D SSFP MRA at 1.5T in 40 patients showed sensitivity of 100% and specificity of 
84% by Maki, et al.in the screening of renal artery stenosis (49). 
 
 
5.ASL(ARTERIAL SPIN LABELLING) WITH SSFP TECHNIQUE: 
 
ASL technique is a qualitative perfusion contrast study to detect changes in cerebral 
blood flow (53).  ASL in combination with SSFP or ECG-gated FSE sequences is also 
used to produce angiographic images. A slab-selective (inversion recovery) IR pulse is 
applied to the image plane and it is combined with an appropriate inversion time. 
Thus, with suppression of the background signals, high signal intensity is obtained 
from inflowing blood from outside the slab.  
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 (Fig.3. Adapted from: (36)) 
 
The advantages of ASL are:  
a) a high signal-to-noise ratio and sufficient suppression of background signals.  
The limitations of ASL are: 
a) the acquisition time is generally longer than without ASL, 
b) by reduced inflow and/or intravoxel dephasing  caused by fast or complex blood 
flow, causing overestimation of  stenosis due to severe signal loss distal to the stenotic 
lesion (54). 
The applications of ASL are: 
a) To image renal arteries, commonly with ECG gating. Wyttenbach et al (54) 
reported high sensitivity (95%–100%), specificity (93%–95%), and negative 
predictive value (99%–100%) for the detection of high-grade renal artery stenosis. 
Lanzman et al also reported  its benefits for the detection of transplant renal artery 
stenosis (55). 
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b) SSFP Angiography with ASL is also used for the portal vein (56) and head and 
neck arteries (57). 
c) Angiography of the abdominal visceral arteries such as the hepatic artery using 
SSFP Angiography with ASL and non-selective and slab-selective IR pulses (58). 
 
 
 
 
6.BLACK BLOOD IMAGING: 
This is another technique of imaging vessels to evaluate intraluminal or mural 
abnormalities. The imaging is based on the ability to suppress signals from flowing 
blood. FSE sequence that uses double IR pulses with ECG gating (60, 61) is the most 
commonly used approach. A non-selective IR pulse is applied followed immediately 
by a section-selective IR pulse. Only those spins within the imaging section are 
returned to their original equilibrium position (59). During diastole when the signals 
from inflowing blood are null after the inversion time, the data are acquired. 
The limitations are:  
a) the relatively long acquisition time due to ECG gating  (59), and 
b) evaluation is limited to single or several 2D slices only. Evaluation of intraluminal 
and mural abnormalities, plaque, dissection and thrombus in the arteries on T1- and 
T2-weighted contrast-enhanced images is feasible. It can differentiate recent 
haemorrhage and the lipid-rich necrotic core (60). As it can provide multi-section 
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images within a short acquisition time without ECG gating (61) it is useful for 
screening for carotid plaque.  
 
(Fig.4. Adapted from: (36).) 
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IV. METHODOLOGY: 
 
A) Study Design:  Study of diagnostic test accuracy   
B) Study Type:  Analytical 
C) Setting:    
 Christian Medical College and Hospital, Vellore.  
D) Inclusion Criteria:  
1. Patients with suspected lower limb peripheral arterial disease, 
undergoing a contrast MR or CT Angiography in our institution. 
     E) Exclusion Criteria: 
1. Those patients with metallic implants 
2. Those patients who refuse to give consent for MRI 
3. Those that cannot cooperate for an MRI 
4. Patients with arrhythmias 
5. Patients < 18 years 
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F) Sample size: 
Based on the Collins et al (2007) (62), the current reference standard test 
has 99% sensitivity as compared to invasive Angiography. Therefore, 
presume the index test (Non contrast MR Angiography) should have 
sensitivity of nearly 90%. By reviewing the range of numbers, we would 
like to study minimum 60 arteries with stenosis for sensitivity. Similar 
number would provide me the specificity around 90%.  
Single Proportion - Absolute Precision 
Sensitivity for (D+) with stenosis 0.9 0.9 0.9 
Precision (%) 10 7.5 5 
Desired confidence level  (1- alpha) % 95 95 95 
Required sample size 35 61 138 
(Fig.5: Sample size calculation) 
 
The above number would be enough to study the second objective 
regarding the agreement between two methods in grading of the stenosis. 
That is, in order to get 90% agreement as compared to 40% (Null 
Hypothesis value), keeping alpha and beta errors at 5% and 20% 
respectively, the sample size needed is 65 arteries. This would be 45, if the 
null hypothesis value is 30%. However, we would like to study 50 arteries 
(any of the lower limb arteries) to study the reliability. Thus the above 
arteries would be enough to study the second objective. 
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This prospective study was approved by the institutional review board for research. 
Patients with suspected peripheral arterial disease who were referred to the radiology 
department for CT or MR Angiography were subjected to non-contrast MR 
Angiography in addition to the primary study. Informed consent was obtained from 
the patients.  
G) Technique of NON contrast MR, contrast MR and CT Angiography: 
Contrast enhanced MR Angiography was performed in the 1.5 T (Avanto, SIEMENS 
Systems, Germany) 
The non-contrast MR Angiography was performed in the Philips INTERNA ACHIEVA 1.5 
T. 
The CT Angiography was performed in the 64 slice GE Discovery 750 HD 
 
CT Angiography was performed in two of the patients and CE-MR Angiography was 
performed as the gold standard in the remaining 8 patients, along with the index test 
(non-contrast MR Angiography). 
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PERFORMING THE CONTRAST MR ANGIOGRAPHY: 
IMAGE ACQUISITION: 
a) MRI scanner 
The MRI machine that was used was 1.5T scanner (SEIMENS 1.5T Avanto TIM). 
b) MRI protocol – Sequences and Technique 
The procedure was explained to the patient and informed consent was obtained.  
An intravenous access with a 3 way extension was established following which the 
patient was placed in the MR gantry. IV tramadol was injected intra muscularly in 
patients with severe ischemic pain. The patient was placed in the supine position with 
feet first in the gantry. 
3 coils were used: 
i) PA (peripheral matrix or boot coil), which cover the thighs, legs and the 
feet, 
ii)  Two body coils (one from mid-thigh to mid-abdomen and one from mid-
abdomen to upper thorax) 
Imaging is done in three stations, starting with the feet upto the abdomen (feet leg, 
legthigh and thigh abdomen), and each taking upto approximately 15 seconds). 
Initial set of images are the localisers, which is a TruFISP image (which is a bright 
blood technique, which is carried out in all three planes, namely, coronal, sagittal and 
50 
 
axial).The pre imaging coronal FLASH 3D sequence is then executed in three stations, 
starting with the feet all the way upto the abdomen (each sequence takes 
approximately 15-20 secs). 
c)Geometric parameters: 
FOV- 500mm; Rectangular FOV- 90%; Slice thickness – 1.2 mm; No slice gap; Slice 
thickness – 90; 371 x 512 matrix; TR-3.12 ms; TE- 1.04 ms; Flip angle- 25%. 
TruFISP abdomen survey was brought into the planner. The trigger was placed on the 
arch of the aorta. This was followed by the CARE bolus technique at which time 
contrast was 15-30 ml of gadolinium was injected manually or using the pressure 
injector, at the rate of 5 ml/ sec and then flushed with 20 ml of saline. 
Dynamic images are then viewed in the auto view display and the scan is commenced 
when contrast is seen entering the aortic arch. Dynamic post contrast images are 
obtained from the abdomen to the feet. 
The whole scan time was approximately 4 mins. Manual subtraction of the pre-
contrast images form the post-contrast images were then performed and loaded onto 
the 3-D card and MIP (maximum intensity projection) images were generated for all 
three stations. The MIP images were then composed for the single image form aorta to 
feet.  
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PERFORMING THE NON CONTRAST MR ANGIOGRAPHY: 
IMAGE ACQUISITION 
 
a) MRI scanner 
The MRI machine that was used was Philips INTERNA ACHIEVA 1.5 T. 
b) MRI protocol – Sequences and Technique 
After explaining the procedure to the patient, the informed consent was obtained.  
 
M2DI SEQUENCE (FOR LOWER LIMB ARTERIES) (a flow compensated gradient 
echo 2D TOF sequence): 
The patient was placed in the supine position with feet first in the gantry for this sequence. 
Only in-built Q body coils were used. 
c)Geometric parameters: 
Coil selection = "Q-Body"; FOV RL (mm) = 400; Slice thickness (mm) = 4; Scan 
mode "M2D"; technique ="FFE"; TE ="out-phase"; (ms) = 6.90647078; Flip angle = 
70 degree; TR ="user defined"; (ms) =20; Cardiac synchronization= "gate"; device 
="ECG"; MIP/MPR = "MIP"; protocol ="compose. 
Images were then acquired in the axial plane and MIP images of the arteries were generated. 
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BTFE SEQUENCE (FOR AORTA AND ILIAC VESSELS) (an ECG-gated SSFP 
sequence): 
The patient was placed in the supine position with head first in the gantry for this sequence. 
In-built Q body coil and the Torso coil were used. 
c)Geometric parameters: 
FOV FH(mm)= 350; FOV RL (mm) = 332; Slice thickness (mm) = ; TE = shortest; 
TR= shortest; Flip angle (deg) = 90; Cardiac synchronization= "gate"; device ="ECG” 
Images were acquired in the coronal plane. 
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ALGORITHM OF METHODOLOGY: 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Patients with suspected lower 
limb peripheral arterial disease, 
in our institution 
Non- contrast MR 
angiography and contrast MR 
or CT angiography 
     Image interpretation by two 
radiologists: 
 - Qualitative 
 - Quantitative  
Comparison of the two tests 
and statistical analysis 
    Conclusion 
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H) Image analysis: 
Two radiologists blinded to subject identity and the overall diagnosis reviewed all 
source and MIP images and graded the quantity of stenosis and the quality of the 
image, independently.  
 
 
 
The lower limb arteries are divided into the following segments: 
1) Aorta 
2) Right common iliac artery  
3) Left common iliac artery  
4) Right external iliac artery 
5) Left external iliac artery 
6) Right common femoral artery  
7) Left common femoral artery  
8) Right superficial femoral artery  
9) Left superficial femoral artery  
10) Right  popliteal artery 
11) Left popliteal artery 
12) Right anterior tibial artery (ATA) 
13) Right common peroneal artery (CPA) 
14) Right posterior tibial artery (PTA) 
15) Left anterior tibial artery (ATA) 
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16) Left common peroneal artery (CPA) 
17) Left posterior tibial artery (PTA) 
In all, 170 arterial segments were analysed in all the 10 patients.  
Each of the arteries was then evaluated and graded qualitatively and quantitatively, by 
two Radiologists, the primary investigator (Radiologist- 2) and the guide (Radiologist-
1) independently.  
 
 
 
The quality of the images for each arterial segment was qualitatively graded as 
follows: 
1- Poor 
2- Fair  
3- Good 
4- Excellent 
 
The degree of stenosis in each artery was quantitatively graded as follows: 
0- 0 % occlusion/ normal/ no occlusion 
1- Less than or equal to 50 % occlusion of the vessel 
2- More than 50 % occlusion of the vessel 
3- Complete / 100 % occlusion of the vessel  
In arteries with more than one stenosis, the higher degree of stenosis was considered. 
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Fig.6: Non- contrast MR angiography 
in a patient with no evidence of 
peripheral arterial disease. 
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Fig.7: Contrast MR Angiography: Grade 1 stenosis in the left 
common iliac artery 
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Fig.8: Contrast MR Angiography: Grade 2 stenosis in the left 
common iliac artery, with grade 3 stenosis in the right 
external iliac artery (*). 
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Fig.9: Contrast MR angiography: Grade 3 stenosis (occlusion) in the left 
superficial femoral artery and grade 2 stenosis in left external iliac 
artery(*). 
61 
 
 
 
 
 
Fig.10:Contrast MR angiography: Grade 3 stenosis 
(occlusion) in the left popliteal artery. 
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V. RESULTS AND ANALYSIS: 
1) DESCRIPTIVE DATA: 
The study data comprised of a total of 170 arterial segments, in 10 patients who were 
recruited into the study. 
 
All patients included in the study were imaged at initial presentation, with no prior 
history of any surgery (stenting / by-pass graft) for peripheral arterial disease. 
All patients were males and all of them had history of smoking. 
The descriptive data of the study group is as shown in Table 1: 
                                         Table 1:      Descriptive Statistics  
( Total number of segments studied= 170 arterial segments) 
Characteristics Minimum Maximum Mean Std. Deviation 
AGE ( in years) 
( no. of patients= 
10) 
34 66 54.40 9.312 
ABPI RIGHT 
INDEX 
.14 1.20 .7440 .30376 
ABPI LEFT INDEX .00 1.10 .6320 .30742 
CLAUDICATION 
DISTANCE(in 
meters) 
0 500 155.00 149.907 
PACK YEARS OF 
SMOKING 
20 40 31.00 5.676 
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a) The age of the patients in the group ranged from 34- 66 years ( mean- 54.40+ 
9.312) 
b) The ABPI ( right side)  ranged from 0.14- 1.20 ( mean- 0.744) 
c) The ABPI ( left side)  ranged from 0.00- 1.10 ( mean- 0.632) 
d) The claudication distance  ranged from 0- 500 meters ( mean- 155.0) 
e) The number of pack years of smoking ranged from 20-40 pack years ( mean-31 
+5.67) 
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Comorbidities: 
a) Eight of the ten patients had diabetes mellitus as shown below: 
 
 
 
 
b) Six of the 10 patients were found to be hypertensive.  
 
 
8, 80% 
2, 20% 
(n= 10) 
DM
No DM
6, 60% 
4, 40% 
(n= 10) 
HTN
No HTN
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2) QUANTITATIVE GRADING OF THE DEGREE OF 
STENOSIS:  
The degree was stenosis (0-0% occlusion; 1-less than or equal to 50% occlusion; 2- 
more than 50% occlusion; 3-100 % occlusion) as graded by radiologist-1 for each of 
the arterial segments was assessed. 
The median of the grading of stenosis of each of the arteries is given below in Table 2. 
                               Table 2: Quantitative analysis 
 Right Limb 
Median (Range) 
Left Limb 
Median (Range) 
 Contrast  
MR / CT 
Non-contrast (Index 
test) 
Contrast  
MR / CT 
Non-contrast (Index 
test) 
Aorta  1(0,3) 0(0,3)   
Common iliac 
artery 
0(0,3) 0(0,2) 1(0,3) 1.5(0,3) 
External iliac  1(0,3) 0.5(0,3) 1.5(0,3) 2(0,3) 
Common femoral  0(0,2) 0(0,3) 0(0,1) 0(0,2) 
Sapheno-femoral  2(0,3) 2(0,3) 3(0,3) 3(0,3) 
Popliteal  0(0,3) 0(0,3) 0(0,3) 0(0,3) 
Anterior tibial  1(0,3) 3(0,3) 2(0,3) 3(1,3) 
Posterior tibial  2(0,3) 0(0,3) 3(0,3) 3(0,3) 
Common 
peroneal  
1(0,3) 2.5(0,3) 0.5(0,3) 3(0,3) 
 
 
Table 2: Data are presented as: Median quantitative grade (minimum-
maximum) for each of the individual arterial segments 
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Table 2 gives the median quantitative grade of each of the arterial segments in the 
index test (Non contrast MR Angiography) and the gold standard test (Contrast MR / 
CT Angiography)  as graded by radiologist- 1. 
 
Of the 170 arterial segments, 95 arterial segments were diseased, with 56 segments 
showing more than 50% degree of stenosis. 
 
 
                               Table 3: Overall Quantitative analysis 
 Contrast  
MR / CT 
Non-contrast 
(Index test) 
P-value 
Degree of 
stenosis 
Median 1 (0-3) 1 (0-3)  
Mean 1.16 ± 1.26 1.38 ± 1.31 0.016 
 
(Table 3)The median degree of stenosis (on a scale from 0 to 3) was found to be 1.00 
in both the index test (Non contrast MR Angiography) and the gold standard test 
(contrast enhanced MR/ CT Angiography), while the mean was found to be 1.38 in the 
index test and 1.16 in the gold standard test, with the p value of 0.016 (<0.05), found 
to be statistically significant. 
 
LENGTH OF STENOSIS: The length of stenosis of the arterial segments (excluding 
infra-popliteal arteries and short segment stenosis) was assessed in the non-contrast, 
the contrast MR and CT Angiography. 
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Artery serial no. Length in non-
contrast MR 
(cm) 
Length in 
contrast MR / 
CTA (cm) 
1 8 6 
2 2 2 
3 2.5 2.5 
4 19.8 18.2 
5 1.4 1.0 
6 1.7 0.8 
7 2.2 2 
8 1.0 1.07 
 
3) GRADING OF THE QUALITY OF THE IMAGES:  
The quality of the image (1- poor; 2- fair; 3- good; 4- excellent) as graded by 
radiologist -1 for each of the arterial segments was assessed. The mean of the scoring 
of the quality of the image of each of the arteries is given below in Table 4. 
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Table 4 gives the median grade for quality of the images in each of the arterial 
segments in the Non contrast MR Angiography and the gold standard test (Contrast 
MR / CT Angiography), as graded by radiologist - 1.  
 
 
 Table 4: Qualitative analysis 
 Right Limb 
Median (Range) 
Left Limb 
Median (Range) 
 Contrast  
MR / CT 
Non-contrast 
(Index test) 
Contrast  
MR / CT 
Non-contrast 
(Index test) 
Aorta  4(4,4) 4(3,4)   
Common iliac 
artery 
4(4,4) 3(2,4) 4(3,4) 3.5(2,4) 
External iliac  4(4,4) 4(2,4) 4(3,4) 4(2,4) 
Common femoral  4(3,4) 4(3,4) 4(3,4) 4(3,4) 
Sapheno-femoral  4(3,4) 4(3,4) 4(3,4) 4(3,4) 
Popliteal  4(3,4) 4(3,4) 4(3,4) 4(4,4) 
Anterior tibial  4(1,4) 2(1,3) 3.5(1,4) 2(1,4) 
Posterior tibial  4(1,4) 1.5(1,4) 3.5(1,4) 2(1,4) 
Common peroneal  3.5(1,4) 1(1,3) 3.5(1,4) 1.5(1,4) 
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(Table 5) The median grade quality of the images (on scale from 1 to 4) was found to 
be 4.00 in both the Non contrast MR Angiography and the gold standard test (contrast 
enhanced MR/ CT Angiography), while the mean was found to be 3.1± 1.13 in the 
index test and 3.64± 0.77  (mean+ standard deviation) in the standard test 
 
 
 
 
 
 
 
 
 
                               Table 5: Overall Qualitative analysis 
 Contrast  
MR / CT 
Non-contrast 
(Index test) 
P-value 
Quality of the 
images 
Median 4 (1-4) 4 (1-4)  
Mean 3.64 ± 0.77 3.10 ± 1.13 0.000 
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4) REGION-WISE ANALYSIS: 
 
The arteries of the lower limbs were divided into 3 regions as follows: 
a. REGION 1- AORTO-ILIAC- abdominal aorta, bilateral common iliac 
arteries and bilateral external iliac arteries. 
b. REGION 2- FEMORO-POPLITEAL- bilateral common femoral arteries 
and superficial femoral arteries and bilateral popliteal arteries. 
c. REGION 3 – ARTERIES IN THE LEG- bilateral common peroneal, 
posterior tibial and anterior tibial arteries. 
 
Each of the arterial regions were then analysed using Cohen’s Weighted Kappa for 
evaluating the efficacy of the index test. Weighted Kappa was used to assess the 
agreement between the degree of stenosis and the quality of images between the non-
contrast and contrast MR/ CT Angiography, based on radiologist-1’s (guide’s) 
interpretation. Weighted Kappa was also used to assess the agreement between the 
degree of stenosis and the quality of images between the two radiologists. 
Sensitivity, specificity, positive predictive value and negative predictive value of non-
contrast MRA for detecting significant stenosis was calculated by considering grade 0 
and 1 as negative and grade 2 and 3 as positive for stenosis.  
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REGION 1: AORTO-ILIAC: 
Kappa 2 x 2 table (Agreement): Agreement of degree of stenosis between NCE-
MRA and CE-MRA/ CTA by radiologist- 1. 
 1 2 Total 
1 6 2 8 
2 3 39 42 
Total 9 41 50 
 
Point estimates and  95 %   Confidence Intervals 
Prevalence Index : -0.66   ( -0.806,  -0.514 ) 
Bias Index : -0.02   ( -0.167,  0.127 ) 
 PABAK :   0.8   ( 0.564,  0.933 ) 
 KAPPA : 0.646   ( 0.361,  0.931 ) 
Testing Kappa Against Null Hypothesis (H0): Kappa = 0 
Proportion Agreement  
Observed Agreement : 0.9 
 Expected Agreement : 0.7176 
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Test Results   
Z - Statistic  : 4.57865 
P - Value : <0.001 
 
 
Diagnostic Performance of NCE-MRA in detecting a significant stenosis: 
 Disease + Disease - Total 
Test + 6  3  9 
Test - 2 39 41 
Total 8 42 50 
 
True prevalence : 0.16   ( 0.072,  0.291 ) 
Sensitivity : 0.75   ( 0.349,  0.968 ) 
Specificity : 0.929   ( 0.805,  0.985 ) 
Positive predictive value : 0.667   ( 0.299,  0.925 ) 
Negative predictive value : 0.951   ( 0.835,  0.994 ) 
Positive likelihood ratio : 10.5   ( 3.287,  33.545 ) 
Negative likelihood ratio : 0.269   ( 0.081,  0.897 ) 
 Odds Ratio : 39   ( 5.358,  283.864 ) 
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Youden Index : 0.679   ( 0.154,  0.953 ) 
 
a) In the aorto-iliac region, the sensitivity was found to be 75 % and the 
specificity 92.9%, with a positive predictive value of 66.7 % and a negative 
predictive value of 95.1%. Weighted Kappa was found to be 0.646. An 
observed agreement of 0.9 was noted between the NCE-MRA and the gold 
standard (contrast MR / CT Angiography). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Fig.11a): Non- contrast MR 
Angiography: Grade 2 stenosis of the 
left external iliac artery and grade 3 
stenosis (occlusion) of the right 
external iliac artery (*). 
 Fig.11b): Contrast MR Angiography: 
Grade 2 stenosis of the left common 
iliac artery and grade 3 stenosis 
(occlusion) of the right external iliac 
artery (*). 
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 Fig.12a): Non- contrast MR 
Angiography: Grade 2 stenosis 
of the left external iliac artery 
and grade 3 stenosis of the right 
external iliac artery (*) (over-
estimation of the length of the 
occluded segment seen in the 
non-contrast study). 
 Fig.12b): Contrast MR 
Angiography: Grade 2 stenosis of 
the left external iliac artery and 
grade 3 stenosis of the right 
external iliac artery (*). 
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SEGMENT 2: FEMORO-POPLITEAL: 
Kappa 2 x 2 table (Agreement): Agreement of the degree of stenosis between 
NCE-MRA and CE-MRA/ CTA by radiologist- 1. 
 
Point estimates and  95 %   Confidence Intervals 
Prevalence Index :  -0.5   ( -0.655,  -0.345 ) 
Bias Index :     0   ( -0.155,  0.155 ) 
 PABAK : 0.933   ( 0.769,  0.992 ) 
 KAPPA : 0.911   (  0.79,  1.032 ) 
Testing Kappa Against Null Hypothesis (H0): Kappa = 0 
Proportion Agreement  
Observed Agreement : 0.96667 
 Expected Agreement : 0.625 
 1 2 Total 
1 14 1 15 
2 1 44 45 
Total 15 45 60 
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Test Results   
Z - Statistic  : 7.05744 
P - Value : <0.001 
 
 
Diagnostic Performance of NCE-MRA in detecting a significant stenosis: 
 Disease + Disease - Total 
Test + 14  1 15 
Test -  1 44 45 
Total 15 45 60 
 
True prevalence : 0.25   ( 0.147,  0.379 ) 
Sensitivity : 0.933   ( 0.681,  0.998 ) 
Specificity : 0.978   ( 0.882,  0.999 ) 
Positive predictive value : 0.933   ( 0.681,  0.998 ) 
Negative predictive value : 0.978   ( 0.882,  0.999 ) 
Positive likelihood ratio : 42   ( 6.019,  293.081 ) 
Negative likelihood ratio : 0.068   ( 0.01,  0.453 ) 
 Odds Ratio : 616   ( 36.124,  10504.403 ) 
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Youden Index : 0.911 ( 0.563,  0.998 ) 
 
b) In the femoro-popliteal region, the sensitivity was found to be 93.3 % and the 
specificity 97.8%, with a positive predictive value of 93.3 % and a negative 
predictive value of 97.8 %. Weighted Kappa was found to be 0.911.  An 
observed agreement of 0.966 was noted between the NCE-MRA and the gold 
standard (contrast MR / CT angiography). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Fig.13a): Non- contrast MR Angiography 
shows grade 3 stenosis in the right 
superficial femoral artery. In this study, 
quality of non-contrast MRA images were 
found to be better than CE-MRA 
 Fig.13b): Contrast MR Angiography: 
Grade 3 stenosis in the right superficial 
femoral artery 
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SEGMENT 3: ARTERIES IN THE LEG: 
Kappa 2 x 2 table (Agreement): Agreement of the degree of stenosis between 
NCE-MRA and CE-MRA/ CTA by radiologist- 1. 
 
 1 2 Total 
1 14 19 33 
2 10 17 27 
Total 24 36 60 
 
Point estimates and  95 %   Confidence Intervals 
Prevalence Index : -0.05   ( -0.206,  0.106 ) 
Bias Index :  0.15   ( -0.027,  0.327 ) 
 PABAK : 0.033   ( -0.232,  0.295 ) 
 KAPPA : 0.052   ( -0.189,  0.293 ) 
Testing Kappa Against Null Hypothesis (H0): Kappa = 0 
Proportion Agreement  
Observed Agreement : 0.51667 
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 Expected Agreement : 0.49 
Test Results   
Z - Statistic  : 0.42376 
P - Value : 0.33587 
 
 
Diagnostic Performance of NCE-MRA in detecting a significant stenosis: 
 Disease + Disease - Total 
Test + 14 19 33 
Test - 10 17 27 
Total 24 36 60 
 
True prevalence : 0.4   ( 0.276,  0.535 ) 
Sensitivity : 0.583   ( 0.366,  0.779 ) 
Specificity : 0.472   ( 0.304,  0.645 ) 
Positive predictive value : 0.424   ( 0.255,  0.608 ) 
Negative predictive value : 0.63   ( 0.424,  0.806 ) 
Positive likelihood ratio : 1.105   ( 0.699,  1.747 ) 
Negative likelihood ratio : 0.882   ( 0.491,  1.585 ) 
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 Odds Ratio : 1.253   ( 0.442,  3.553 ) 
Youden Index : 0.56 ( -0.33,  0.424 ) 
 
 
a) In the legs, the sensitivity was found to be 58.3 % and the specificity 47.2%, 
with a positive predictive value of 42.4 % and a negative predictive value of 63 
%. Weighted Kappa was found to be 0.052 (p=0.336).  An observed agreement 
of 0.516 was noted between the NCE-MRA and the gold standard (contrast MR 
/ CT angiography). 
  
            
 
 
 
 Fig.14a): Non- contrast MR 
Angiography of the arteries of the 
leg, showing grade 3 stenosis 
(occlusion) of bilateral ATA, PTA 
and CPA. 
 Fig.14b): Contrast MR 
Angiography of the arteries of 
the leg, showing grade 3 
stenosis (occlusion) of bilateral 
ATA, PTA and CPA. 
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 Fig.15a): Non- contrast MR 
Angiography of the infra-popliteal 
arteries shows grade 3 stenosis 
(occlusion) of the right PTA and 
CPA and the left PTA and ATA 
proximally. Distal portions were 
better demonstrated on non-contrast 
MRA 
 Fig.15b): Contrast MR Angiography 
of the infra-popliteal arteries shows  
that the proximal portions are patent 
with grade 3 stenosis (occlusion) of 
the right PTA and CPA distally and 
the left  ATA. 
82 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Fig.16a): Non- contrast MR 
Angiography of the infra-
popliteal arteries shows grade 3 
stenosis at the origin of the left 
ATA. 
 Fig.16b): Contrast MR Angiography of 
the infra-popliteal arteries shows no 
stenosis at the origin of the left ATA. 
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5) OBJECTIVE- 2: CORRELATION BETWEEN THE 
RADIOLOGISTS: 
 
 
 Table Cohen’s Weighted kappa for the two radiologists: Quantitative grading 
1 2 3 4 
136 5 1 0 
5 56 5 1 
0 1 23 3 
0 0 3 101 
Observed Agreement (%): 97.451 
 Expected Agreement (%): 53.685 
 Kappa (95% CI) : 0.945   ( 0.923,  0.967 ) 
 Z  - Statistic : 21.494 
 Prob > Z (P - Value) : <0.001 
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In terms of the quantitative grading of the degree of stenosis, the observed agreement 
between the two radiologists was 97.45% with weighted Kappa (95% CI) being 0.945 
(0.923, 0.967) p<0.001. 
 
 
 
 
 
 
         Table Cohen’s Weighted kappa for two radiologists: Qualitative grading 
1 2 3 4 
35 0 0 0 
0 18 6 0 
0 0 51 7 
0 0 12 207 
Observed Agreement (%): 97.52 
Expected Agreement (%): 69.233 
 Kappa (95% CI) : 0.919   ( 0.887,  0.952 ) 
 Z  - Statistic : 21.782 
Prob > Z (P - Value) : <0.001 
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In terms of the grading the quality of images, the observed agreement between the two 
radiologists was 97.52% with weighted Kappa (95% CI) being 0.919 (0.887, 0.952) 
p<0.001. 
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VI. DISCUSSION: 
 
Peripheral arterial occlusive disease has been found to be prevalent in the elderly age 
group. 
Cross-sectional diagnostic imaging is indispensable for planning of interventional and 
surgical procedures.  
Conventional intra-arterial angiography or digital subtraction angiography, the gold-
standard is an invasive technique associated with risks such as ionising radiation, and 
nephrotoxic iodinated contrast media and hospitalisation costs. 
CT angiography (CTA) though a non- invasive study which yields high spatial 
resolution images, is associated with the risk of iodinated contrast induced 
nephropathy and harmful effects of ionizing radiation. 
The use of contrast is of particular concern in these patients with PAOD, who are at an 
increased risk of renal involvement.  
3-D contrast enhanced MR angiography, another useful technique is also of particular 
concern, in view of nephrogenic systemic fibrosis in patients with renal dysfunction.  
Non contrast MR angiography, safe in patients with renal failure, also has certain 
limitations, namely lengthy acquisition times and overestimation of the degree of 
stenosis. 
Newer modifications of non-contrast MR angiography with ECG triggered balanced 
steady state free precession (bSSFP) and modified TOF yield good images. However, 
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literature is scanty in this newer technique of non-contrast MR angiography in patients 
with PAOD. 
 
The present study was planned to evaluate the utility of non- contrast MR angiography 
(using ECG triggered balanced steady state free precession (bSSFP), a novel 
technique and 3-D TOF (time of flight)) in the evaluation of peripheral arterial disease 
of lower limbs.  
Patients with peripheral arterial disease undergoing MR / CT angiography in our 
institution were selected for the study and were subjected to a non- contrast MR 
angiography (ECG- gated 3-D TOF and ECG- gated SSFP) and contrast MR 
angiography or a CT angiography. Each non-contrast MR angiography was carried 
out in approximately 30-40 minutes while the contrast MR angiography and each CT 
angiography study was completed in about 5 minutes.  
The images were then evaluated independently by two radiologists. The evaluation 
included the grading of the degree of stenosis and qualitative assessment of the 
images obtained, in each of the arterial segments. 
The data obtained was then analysed with a view to study the diagnostic efficacy of 
the non- contrast technique as well as the inter-observer variability. 
In this study of 170 arterial segments in 10 patients, the data obtained from the two 
radiologists were entered in EPIDATA and analysed using SPSS and an indigenous 
software developed by the Biostatistics Department in our institution. Sensitivity, 
specificity, positive predictive, negative predictive value and Cohen’s weighted 
Kappa were estimated.    
88 
 
1) QUANTITATIVE GRADING OF THE DEGREE OF STENOSIS:  
Overall (including all the arterial segments), the mean of the quantitative 
degree of stenosis of the arteries in the non-contrast MRA was found to be 
similar to the gold standard (CE-MRA / CT angiography). The non-contrast 
MR Angiography test was however found to overestimate the length of the 
stenosis, especially when the length of the stenosis was relatively shorter.   
Largest length of stenosis was found to be 19.8 cm. 
2) GRADING OF THE QUALITY OF IMAGES:  
Overall (including all the arterial segments), the mean of the qualitative grading 
of the in the non-contrast MRA was found to be nearly as good as the gold 
standard (CE-MRA / CT angiography). In a few of the cases, the quality of the 
non-contrast MRA images was found to be better than the CE-MRA. 
 
3) REGION-WISE ANALYSIS: 
a) In the aorto-iliac region, the sensitivity was found to be 75 % and the 
specificity 92.9%, with a positive predictive value of 66.7 % and a negative 
predictive value of 95.1%. Grades 0 and 1 were considered as negative for 
significant stenosis while grades 2 and 3 were positive for significant stenosis, 
while calculating the sensitivity and this explains the possible reason  for the  
sensitivity being only 75%. Weighted Kappa was found to be 0.646, suggestive 
of a good correlation(63).  An observed agreement of 0.9 was noted between 
the non-contrast MRA and the gold standard (contrast MR / CT angiography). 
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b) In the femoro-popliteal region, the sensitivity was found to be 93.3 % and the 
specificity 97.8%, with a positive predictive value of 93.3 % and a negative 
predictive value of 97.8 %. Weighted Kappa was found to be 0.911, suggestive 
of excellent correlation(63).  An observed agreement of 0.966 was noted 
between the non-contrast MRA and the gold standard (contrast MR / CT 
angiography). 
c) In the legs, the sensitivity was found to be 58.3 % and the specificity 47.2%, 
with a positive predictive value of 42.4 % and a negative predictive value of 63 
%. Weighted Kappa was found to be 0.052, suggestive of poor correlation(63).  
An observed agreement of 0.516 was noted between the non-contrast MRA and 
the gold standard (contrast MR / CT angiography). 
 
 
 
In one of the assessed cases, where there was a discrepancy in the degree of the 
stenosis of the arteries of the leg in the index test and the contrast MR 
angiography, findings were correlated with an USG- Doppler and the findings 
in the NCE-MRA was found to be more accurate than the CE-MRA. 
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 Fig.17a): Non- contrast MR 
Angiography of the arteries of 
the leg, which showed flow in 
the right PTA, with grade 3 
stenosis(occlusion) in the right 
ATA(*) (overestimation of 
stenosis). 
 Fig.17b): Contrast MR 
Angiography of the arteries of 
the leg, which showed no flow 
in the right PTA distally, with 
only grade 1 stenosis in the 
right ATA(*). 
 Fig.18: Doppler 
confirmed flow in the 
right PTA; however there 
was a dampened 
monophasic flow due to 
proximal SFA stenosis 
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 Fig.19: Doppler 
confirmed flow in the 
right ATA; however there 
was a dampened  
monophasic flow due to 
proximal SFA stenosis 
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d) CT angiography was performed in two of the patients and CE-MR angiography 
was performed as the gold standard in the remaining 8 patients, along with 
the non-contrast MR angiography. 
 
               
 
 
 
 Fig.20a): Non-contrast MR 
Angiography of the arteries of the 
lower limb 
 Fig.20b): CT Angiography 
of the arteries of the lower 
limb 
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4) OBJECTIVE- 2: ASSESSMENT BETWEEN THE RADIOLOGISTS: 
a) In terms of the quantitative grading, the observed agreement between the 
two radiologists was 97.45% with weighted Kappa (95% CI) being 0.945 
(0.923, 0.967), suggestive of excellent agreement between the two 
radiologists. 
b) In terms of the qualitative grading, the observed agreement between the two 
radiologists was 97.52% with weighted Kappa (95% CI) being 0.919 
(0.887, 0.952), suggestive of excellent agreement between the two 
radiologists. 
 
 
 
PROBLEMS FACED IN THIS STUDY: 
1) Relatively long durations of the non-contrast MRA. 
2) The non-contrast MRA could not be performed in uncooperative patients 
3) In the assessment of the arteries of the leg, the quality of the non-contrast 
images were inadequate, especially in regions where the arteries take a curved 
course or near the origins of the arteries of the leg. 
 
 
 
 
94 
 
VII. LIMITATIONS: 
1) Relatively small sample size in this study. 
2) Comparison of non-contrast study was done with CE-MRA and CTA rather 
than with DSA (digital subtraction angiography), which is the gold standard. 
The gold standard was however avoided since it is an invasive procedure with 
associated harmful effects of radiation.  
3) The two radiologists analysing the images were not blinded to the technique to 
study (whether non-contrast MRA/ CE-MRA / CTA); however the non-
contrast and CE-MRA/CTA images of each patient were not analysed at the 
same time.   
 
 
 
 
 
 
 
 
 
 
 
 
 
95 
 
 
 
VIII. CONCLUSION: 
In this prospective study, non-contrast MR angiography was compared with contrast 
MR/ CT Angiography, in 170 arterial segments. 
i) Overall the estimation of the degree of stenosis of the arteries in the non-
contrast MRA was found to be similar to the gold standard (CE-MRA / CT 
angiography). The non-contrast MR Angiography was however found to 
overestimate the length of the stenosis, especially when the length of the 
stenosis was relatively shorter.  
ii) Overall quality of non-contrast MRA images was found to be nearly as 
good as the gold standard (CE-MRA / CT angiography). The quality was 
excellent for aorto-iliac segments, good for femoro-popliteal segments and 
poor in the infra-popliteal segments. In a few of the cases, the quality of the 
non-contrast MRA images was found to be better than the CE-MRA. 
iii) In the aorto-iliac region, the sensitivity of the non-contrast MRA for 
detecting a significant stenosis was found to be 75 % and the specificity 
92.9%, with a positive predictive value of 66.7 % and a negative predictive 
value of 95.1%. Weighted Kappa was found to be 0.646, suggestive of good 
correlation. 
iv) In the femoro-popliteal region, the sensitivity of the non-contrast MRA was 
found to be 93.3 % and the specificity 97.8%, with a positive predictive 
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value of 93.3 % and a negative predictive value of 97.8 %. Weighted Kappa 
was found to be 0.911, suggestive of excellent correlation. 
v) In the legs, the sensitivity of the non-contrast MRA was found to be 58.3 % 
and the specificity 47.2%, with a positive predictive value of 42.4 % and a 
negative predictive value of 63 %. Weighted Kappa was found to be 0.052, 
suggestive of poor correlation(63).   
 
In summary, non-contrast MR Angiography was found to be comparable to 
the contrast MR / CT Angiography in the evaluation of the arteries of the 
lower limbs, in peripheral arterial disease. Non-contrast MR Angiography 
can hence be used as an alternative and safe imaging modality in the 
evaluation of PAOD, thus avoiding the risks associated with contrast MR/ 
CT Angiography. In few instances, it proved to be even better than the 
contrast MRA. Non-contrast MRA is especially helpful in assessing the 
aorto-iliac vessels and femoro-popliteal vessels with slightly suboptimal 
imaging of infra-popliteal arterial segments. Further studies and more 
robust non-contrast MRA techniques need to be developed for better 
evaluation of the infra-popliteal arteries.  
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APPENDIX 1 - PROFORMA: 
Name: 
Age: 
Sex: 
Hospital number: 
Contact details:  
Phone no: 
Address: 
Comorbidities: 
1) DM: 
2) HTN: 
3) Smoking: 
4) Alcohol consumption: 
5) Clinical data: Claudication distance, ABPI 
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Appendix 2 – Consent form and patient information sheet 
Appendix 3 –   Abbreviations  
Appendix 4 –   Master table 
                       Additional tables and figures 
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APPENDIX 2- 
       
Department of Radiodiagnosis, Christian Medical College, Vellore 
 
Study Title: DIAGNOSTIC ACCURACY OF NON-CONTRAST MAGNETIC RESONANCE 
ANGIOGRAPHY IN PERIPHERAL ARTERIAL DISEASE AS COMPARED TO CONTRAST 
ENHANCED MAGNETIC RESONANCE ANGIOGRAPHY AND COMPUTED TOMOGRAPHY 
ANGIOGRAPHY. 
 
PATIENT INFORMATION SHEET 
 
You are being requested to participate in a study to see if Non contrast magnetic resonance ( 
MR) angiography can adequately / clearly  assess peripheral arterial disease as well as a 
contrast magnetic resonance (MR)/ CT angiography. 
The knowledge of this test for the assessment of peripheral arterial disease is not clearly 
known. Hence we hope to find out whether this scan can clearly assess peripheral arterial 
disease. 
What additional tests do I have to go through if I take part in this study? 
If you take part in this study, your contrast magnetic resonance (MR)/ CT angiography scan 
will be done as a routine test as prescribed by your clinician. An additional non contrast 
magnetic resonance (MR) angiography will also be done at the same time. You will not have 
to pay any additional amount for the additional scan. 
Does  magnetic resonance ( MR) angiography  have any side effects?  
MRI scan does not have any harmful radiation. It is a painless non-invasive study. We will be 
doing it the same way as you would have it if you were not included in this study. 
If I take part in this study, what will I have to do? 
If you agree to participate in this study, there will be no change in the other investigations and 
treatment that you will be receiving.   
Can I withdraw from this study after it starts? 
Your participation in this study is entirely voluntary and you are also free to decide to 
withdraw permission to participate in this study. If you do so, this will not affect your usual 
treatment at this hospital in any way.  
What will happen if I develop any study related injury? 
This scan does not involve harmful radiation and it is completely non- invasive.  So, we do 
not expect any procedure related injury. However you can immediately report to us. 
Will I have to pay for the additional tests?   
You will not be charged additional amount for this scan. All other investigations, as 
requested by your doctor will continue in the usual manner. How much you pay for these 
investigations will not change and this has nothing to do with your participation in this study.  
What happens after the study is over? 
You may or may not benefit from this study. Once the study is over, we will analyze the 
results and come to a conclusion if non contrast MR angiography is as good as contrast MR 
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angiography in assessing peripheral arterial disease. 
Will my personal details be kept confidential? 
The results of this study will/may be published in a medical journal but you will not be 
identified by name in any publication or presentation of results. However, your medical 
record may be reviewed by doctors associated with the study, without your additional 
permission. 
If you have any further questions, please contact Dr. Soumya Regi (Tel: 0416 228-
3012/2027/3609) between 8am & 4:30pm from Monday to Friday and from 8am to 
12:30pm on Saturday or you can email your queries to soumyaregi@gmail.com  
Department of Radiodiagnosis, Christian Medical College, Vellore 
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CONSENT FORM 
 
Study Title: DIAGNOSTIC ACCURACY OF NON-CONTRAST MAGNETIC RESONANCE 
ANGIOGRAPHY IN PERIPHERAL ARTERIAL DISEASE AS COMPARED TO 
CONTRAST ENHANCED MAGNETIC RESONANCE ANGIOGRAPHY AND COMPUTED 
TOMOGRAPHY ANGIOGRAPHY. 
 
Study Number: 
Patient’s name:  
Hospital No: 
Date of Birth / Age (in years):  
 
 
I ______________________, father / mother of the patient named 
______________________ 
declare that I have read / been read to the information sheet provided to me regarding this 
study and have clarified any doubts that I had. [  ] 
 
(Please tick boxes) 
I also understand that my participation in this study is entirely voluntary and that I am free to 
withdraw permission to continue to participate at any time without affecting patient’s usual 
treatment or legal rights [  ]  
 
I understand that study staff and institutional ethics committee will not need my permission to 
look at patient’s health records if I withdraw from the trial. I agree to this access [  ]  
 
I agree not to restrict the use of any data or results that arise from this study provided such a 
use is only for scientific purpose(s) [  ] 
 
I understand that patient’s identity will not be revealed in any information released to third 
parties or published [  ]   
 
I voluntarily agree to take part in this study [  ] 
 
 
Name: 
Relation to the patient:  
Signature/thumb impression: 
Date: 
 
 
Name of witness: 
Relation to participant: 
Date: 
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APPENDIX 3- 
 
ABBREVIATIONS: 
ABI- Ankle- brachial index  
ABPI - Ankle- brachial pressure index 
ACC/AHA- American College of Cardiology, American Heart Association  
AKI- acute kidney injury  
ASL- Arterial spin labelling 
b-SSFP- balanced steady state free precession 
CE-MRA- contrast enhanced magnetic resonance angiography 
CPR- Curved planar reformations  
CTA- Computed tomography angiography 
eGFR- estimated glomerular filtration rate  
FASE- fast asymmetric spin echo 
FBI- Fresh blood imaging 
FDA- Food and Drug Administration  
FFE- Fast field echo 
FIESTA- fast imaging employing steady state acquisition 
Gd- Gadolinium 
Gradient- echo (GRE) 
IR- Inversion recovery 
MDCT- Multi-detector row CT 
mDixon - Modified Dixon  
MIP- Maximum intensity projection  
MRA- Magnetic resonance angiography 
NCE-MRA- Non-contrast enhanced magnetic resonance angiography 
NSF- Nephrogenic systemic fibrosis 
PAOD - Peripheral arterial occlusive disease   
PSV- Peak systolic velocity 
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RARE- rapid acquisition with relaxation enhancement  
RF- Radiofrequency  
SNR- Signal to noise ratio 
SSFP- Steady state free precession 
SSFSE- single-shot FSE SSFSE 
SSTSE- single-shot turbo spin echo   
TOF- Time of Flight angiography 
TRANCE- Triggered angiography non-contrast-enhanced 
True FISP- Fast imaging with steady-state precession 
VR- volume rendered 
 
Abbreviations in the master table: 
idno      IDENTIFICATION NUMBER     
NAME      NAME OF PATIENT        
HOSPNO    HOSPITAL NUMBER      
LB        limb                      
AACQLR1   AORTA CONTRAST QUALIT RADIOLOGIST-1              
AACQLR2   AORTA CONTRAST QUALIT RADIOLOGIST -2                 
AANQLR1   AORTA NONCONTRAST QUALIT RADIOLOGIST -1            
AANQLR2   AORTA NONCONTRAST QUALIT RADIOLOGIST -2          
CIACQLR1  CIA CONTRAST QUALIT RADIOLOGIST -1             
CIACQLR2  CIA CONTRAST QUALIT RADIOLOGIST -2              
CIANQLR1  CIA NONCONTRAST QUALIT RADIOLOGIST -1            
CIANQLR2  CIA NONCONTRAST QUALIT RADIOLOGIST -2                
EIACQLR1  EIA CONTRAST QUALIT RADIOLOGIST -1                   
EIACQLR2  EIA CONTRAST QUALIT RADIOLOGIST -2                
EIANQLR1  EIA NONCONTRAST QUALIT RADIOLOGIST -1            
EIANQLR2  EIA NONCONTRAST QUALIT RADIOLOGIST -2               
CFACQLR1  CFA CONTRAST QUALIT RADIOLOGIST -1                          
CFACQLR2  CFA CONTRAST QUALIT RADIOLOGIST -2                 
CFANQLR1  CFA NONCONTRAST QUALIT RADIOLOGIST -1             
CFANQLR2  CFA NONCONTRAST QUALIT RADIOLOGIST -2               
109 
 
SFACQLR1  SFA CONTRAST QUALIT RADIOLOGIST -1                 
SFACQLR2  SFA CONTRAST QUALIT RADIOLOGIST -2                 
SFANQLR1  SFA NONCONTRAST QUALIT RADIOLOGIST -1             
SFANQLR2  SFA NONCONTRAST QUALIT RADIOLOGIST -2                 
POPACQLR1  POPA CONTRAST QUALIT RADIOLOGIST -1             
POPACQLR2  POPA CONTRAST QUALIT RADIOLOGIST -2              
POPANQLR1  POPA NONCONTRAST QUALIT RADIOLOGIST -1         
POPANQLR2  POPA NONCONTRAST QUALIT RADIOLOGIST -2                 
ATACQLR1   ATA CONTRAST QUALIT RADIOLOGIST -1             
ATACQLR2   ATA CONTRAST QUALIT RADIOLOGIST -2              
ATANQLR1   ATA NONCONTRAST QUALIT RADIOLOGIST-1           
ATANQLR2   ATA NONCONTRAST QUALIT RADIOLOGIST-2           
PTACQLR1   PTA CONTRAST QUALIT RADIOLOGIST -1               
PTACQLR2   PTA CONTRAST QUALIT RADIOLOGIST -2              
PTANQLR1   PTA NONCONTRAST QUALIT RADIOLOGIST -1               
PTANQLR2   PTA NONCONTRAST QUALIT RADIOLOGIST -2            
CPACQLR1   CPA CONTRAST QUALIT RADIOLOGIST -1                 
CPACQLR2   CPA CONTRAST QUALIT RADIOLOGIST -2                
CPANQLR1   CPA NONCONTRAST QUALIT RADIOLOGIST -1            
CPANQLR2   CPA NONCONTRAST QUALIT RADIOLOGIST -2                 
AACQTR1    AORTA CONTRAST QUANTIT RADIOLOGIST -1                 
AACQTR2    AORTA CONTRAST QUANTIT RADIOLOGIST -2                 
AANQTR1    AORTA NONCONTRAST QUANTIT RADIOLOGIST -1              
AANQTR2    AORTA NONCONTRAST QUANTIT RADIOLOGIST -2              
CIACQTR1   CIA CONTRAST QUANTIT RADIOLOGIST -1                   
CIACQTR2   CIA CONTRAST QUANTIT RADIOLOGIST -2                   
CIANQTR1   CIA NONCONTRAST QUANTIT RADIOLOGIST -1                
CIANQTR2   CIA NONCONTRAST QUANTIT RADIOLOGIST -2                
EIACQTR1   EIA CONTRAST QUANTIT RADIOLOGIST -1                   
EIACQTR2   EIA CONTRAST QUANTIT RADIOLOGIST -2                   
EIANQTR1   EIA NONCONTRAST QUANTIT RADIOLOGIST -1                 
EIANQTR2   EIA NONCONTRAST QUANTIT RADIOLOGIST -2             
CFACQTR1   CFA CONTRAST QUANTIT RADIOLOGIST -1                  
CFACQTR2   CFA CONTRAST QUANTIT RADIOLOGIST -2                   
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CFANQTR1   CFA NONCONTRAST QUANTIT RADIOLOGIST -1                  
CFANQTR2   CFA NONCONTRAST QUANTIT RADIOLOGIST -2                           
SFACQTR1   SFA CONTRAST QUANTIT RADIOLOGIST -1                 
SFACQTR2   SFA CONTRAST QUANTIT RADIOLOGIST -2                
SFANQTR1   SFA NONCONTRAST QUANTIT RADIOLOGIST -1                 
SFANQTR2   SFA NONCONTRAST QUANTIT RADIOLOGIST -2                 
POPACQTR1  POPA CONTRAST QUANTIT RADIOLOGIST -1                 
POPACQTR2  POPA CONTRAST QUANTIT RADIOLOGIST -2                  
POPANQTR1  POPA NONCONTRAST QUANTIT RADIOLOGIST -1                
POPANQTR2  POPA NONCONTRAST QUANTIT RADIOLOGIST -2              
ATACQTR1   ATA CONTRAST QUANTIT RADIOLOGIST -1               
ATACQTR2   ATA CONTRAST QUANTIT RADIOLOGIST -2               
ATANQTR1   ATA NONCONTRAST QUANTIT RADIOLOGIST -1          
ATANQTR2   ATA NONCONTRAST QUANTIT RADIOLOGIST -1           
PTACQTR1   PTA CONTRAST QUANTIT RADIOLOGIST -1             
PTACQTR2   PTA CONTRAST QUANTIT RADIOLOGIST -2               
PTANQTR1   PTA NONCONTRAST QUANTIT RADIOLOGIST -1               
PTANQTR2   PTA NONCONTRAST QUANTIT RADIOLOGIST -2             
CPACQTR1   CPA CONTRAST QUANTIT RADIOLOGIST -1              
CPACQTR2   CPA CONTRAST QUANTIT RADIOLOGIST -2           
CPANQTR1   CPA NONCONTRAST QUANTIT RADIOLOGIST -1          
CPANQTR2   CPA NONCONTRAST QUANTIT RADIOLOGIST -2          
 
CIA- Common iliac artery 
EIA- External iliac artery 
CFA- common femoral artery 
SFA- superficial femoral artery 
POPA- popliteal artery 
ATA- Anterior tibial artery 
PTA- Posterior tibial artery 
CPA- Common peroneal artery 
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APPENDIX 4- 
 
MASTER TABLES: 
 
ADDITIONAL TABLES: 
                               Table 2: Quantitative analysis 
 Right Limb 
Median (Range) 
Left Limb 
Median (Range) 
 Contrast  
MR / CT 
Non-
contrast 
(Index test) 
P 
value 
Contrast  
MR / CT 
Non-
contrast 
(Index test) 
 
Aorta  1(0,3) 0(0,3) 0.157    
Common iliac 
artery 
0(0,3) 0(0,2) 0.414 1(0,3) 1.5(0,3) 0.257 
External iliac  1(0,3) 0.5(0,3) 1.000 1.5(0,3) 2(0,3) 
0.414 
Common 
femoral  
0(0,2) 0(0,3) 0.713 0(0,1) 0(0,2) 0.317 
Sapheno-
femoral  
2(0,3) 2(0,3) 0.317 3(0,3) 3(0,3) 0.157 
Popliteal  0(0,3) 0(0,3) 0.317 0(0,3) 0(0,3) 0.317 
Anterior tibial  1(0,3) 3(0,3) .063 2(0,3) 3(1,3) 0.102 
Posterior tibial  2(0,3) 0(0,3) 0.672 3(0,3) 3(0,3) 
0.785 
Common 
peroneal  
1(0,3) 2.5(0,3) 0.179 0.5(0,3) 3(0,3) 
0.172 
 
 
Table 2: Data are presented as: Median quantitative grade (minimum-
maximum) for each of the individual arterial segments 
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Table 4 gives the median grade for quality of the images in each of the arterial 
segments in the Non contrast MR angiography and the gold standard test (Contrast 
MR / CT angiography), as graded by radiologist - 1.  
 Table 4: Qualitative analysis 
 Right Limb 
Median (Range) 
Left Limb 
Median (Range) 
 Contrast  
MR / CT 
Non-
contras
t 
(Index 
test) 
P 
valu
e 
Contrast  
MR / 
CT 
Non-
contras
t 
(Index 
test) 
P value 
Aorta  4(4,4) 4(3,4) 0.157    
Common iliac 
artery 
4(4,4) 3(2,4) 0.020 4(3,4) 3.5(2,4) 0.059 
External iliac  4(4,4) 4(2,4) 
0.059 
4(3,4) 4(2,4) 0.157 
Common femoral  4(3,4) 4(3,4) 1.000 4(3,4) 4(3,4) 1.000 
Sapheno-femoral  4(3,4) 4(3,4) 0.157 4(3,4) 4(3,4) 0.564 
Popliteal  4(3,4) 4(3,4) 1.000 4(3,4) 4(4,4) 0.157 
Anterior tibial  4(1,4) 2(1,3) 0.007 3.5(1,4) 2(1,4) 0.075 
Posterior tibial  4(1,4) 1.5(1,4) 0.014 3.5(1,4) 2(1,4) 0.230 
Common peroneal  3.5(1,4) 1(1,3) 0.011 3.5(1,4) 1.5(1,4) 0.187 
 MASTER TABLES: 
 
QUANTITATIVE GRADING OF THE DEGREE OF STENOSIS:  
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1 B A 192594G 2 9 9 9 9 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 0 0 0 0 3 3 3 3 3 2 3 3 1 2 3 3 
2 B A 192594G 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 2 2 3 1 2 3 3 
3 B D 859725F 1 0 0 0 0 0 0 0 0 3 2 2 2 0 0 0 0 0 0 0 0 0 0 0 0 1 1 1 1 2 2 3 3 3 3 2 3 
4 B D 859725F 2 9 9 9 9 0 0 0 0 2 2 2 1 0 0 0 0 3 3 3 3 0 0 0 0 3 3 2 2 2 2 3 3 0 0 3 3 
5 N D 862089F 1 1 0 0 0 1 1 1 1 1 2 2 2 2 2 0 0 3 3 3 3 0 0 0 0 1 1 3 3 3 3 1 3 1 1 0 1 
6 N D 862089F 2 9 9 9 9 0 1 1 1 2 2 3 3 0 0 0 0 3 3 3 3 3 3 0 0 3 3 3 3 3 3 0 0 3 3 0 0 
7 S 839739F 1 3 3 3 3 3 3 2 2 0 0 0 0 1 0 0 0 1 1 0 0 0 0 0 0 0 1 3 3 3 3 3 3 0 0 0 2 
8 S 339739F 2 9 9 9 9 3 3 3 3 1 0 3 3 0 0 0 0 1 1 0 0 0 0 0 0 0 0 3 3 3 3 1 2 0 0 3 3 
9 J B 370783D 1 1 1 1 1 1 1 1 1 2 2 3 3 1 1 0 0 1 1 1 1 0 0 0 0 0 0 3 3 0 0 3 3 0 0 3 3 
10 J B 370783D 2 9 9 9 9 1 2 2 2 3 3 3 3 1 1 2 2 1 1 1 1 0 0 0 0 0 0 3 3 1 0 3 3 0 0 3 3 
11 M 301037G 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 3 3 3 2 2 2 3 0 0 3 3 
12 M 301037G 2 9 9 9 9 1 1 0 0 1 1 0 0 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 
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14 N B 296207G 2 9 9 9 9 2 2 2 2 2 2 2 2 0 0 0 0 1 1 0 0 0 0 0 0 1 1 1 1 3 3 3 3 0 0 0 0 
15 DC 254303G 1 1 0 0 0 0 0 1 1 1 1 0 0 0 0 0 0 3 3 3 3 0 0 0 0 0 0 2 2 0 0 3 3 0 0 3 3 
16 D C  254303G 2 9 9 9 9 1 1 1 1 1 1 1 1 1 1 1 1 3 3 3 3 0 0 0 0 0 0 2 2 3 3 3 3 0 0 3 3 
17 N N 307965G 1 1 1 1 1 0 0 0 0 1 1 1 1 0 0 0 0 3 3 3 3 1 1 1 1 0 0 0 0 0 0 0 0 1 1 2 2 
18 N N 307965G 2 9 9 9 9 3 3 3 3 3 3 3 3 1 1 1 1 3 3 3 3 0 0 0 0 0 0 1 1 0 0 0 0 1 1 2 2 
19 B K  312875G 1 1 1 1 1 0 0 2 2 0 0 0 0 0 0 0 0 3 3 3 3 3 3 3 3 3 3 3 3 0 1 0 1 3 3 1 1 
20 B K  312875G 2 9 9 9 9 0 0 2 2 0 0 0 0 1 1 1 1 3 3 3 3 3 3 3 3 3 3 3 3 0 0 1 1 3 3 1 1 
  
QUALITATIVE GRADING OF THE DEGREE OF STENOSIS:  
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1 B A 192594G 2 9 9 9 9 4 4 3 3 4 4 3 3 4 4 4 3 4 4 4 4 4 4 4 4 4 3 2 2 4 4 2 3 4 4 2 2 
2 B A 192594G 1 4 4 4 3 4 4 3 3 4 4 3 3 4 4 4 3 4 4 4 4 4 4 4 4 4 3 2 2 4 4 2 2 4 4 2 2 
3 B D 85F9725 1 4 4 4 4 4 4 3 3 4 4 2 3 4 4 4 4 4 4 4 3 4 4 4 4 4 4 1 1 4 4 1 1 4 4 1 1 
4 B D 859725F 2 9 9 9 9 4 4 3 3 4 4 2 3 4 4 4 4 4 4 3 4 4 4 4 4 4 4 1 1 4 4 1 1 4 4 1 1 
5 N D 862089F 1 4 4 4 4 4 3 3 3 4 4 3 4 4 4 4 4 3 3 3 3 4 4 4 4 4 3 2 2 4 3 2 3 3 3 2 2 
6 N D 862089F 2 9 9 9 9 3 3 3 3 3 3 4 4 4 4 4 4 3 3 4 3 3 4 4 4 1 1 1 1 1 1 4 3 1 1 4 3 
7 S 839739F 1 4 4 3 3 4 4 2 3 4 4 4 4 3 3 4 4 3 3 4 4 3 3 4 4 3 3 1 1 3 3 1 1 3 3 1 1 
8 S 339739F 2 9 9 9 9 4 4 2 3 4 4 3 4 3 3 4 4 3 3 4 4 3 3 4 4 3 3 1 1 3 3 1 1 3 3 1 1 
9 J B 370783D 1 4 4 3 4 4 4 3 3 4 4 3 3 4 4 3 3 4 4 4 4 4 4 4 4 4 4 1 1 4 4 1 1 4 4 1 1 
10 J B 370783F 2 9 9 9 9 4 4 3 3 4 4 3 3 4 4 3 3 4 4 4 4 4 4 4 4 4 4 2 2 4 4 2 2 4 4 1 1 
11 M 301037G 1 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 1 1 9 9 1 1 1 1 1 1 1 1 
12 M 301037G 2 9 9 9 9 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 9 9 9 9 1 1 1 1 1 1 1 1 1 1 1 1 
13 N B 296207G 1 4 4 4 4 4 4 3 3 4 4 4 4 4 4 4 4 3 4 4 4 4 4 3 4 4 4 3 3 3 3 4 4 3 3 9 9 
14 N B 296207G 2 9 9 9 9 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 2 2 4 4 2 2 4 4 2 2 4 4 
15 DC 254303G 1 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 3 3 4 4 1 1 4 4 1 1 
16 D C  254303G 2 9 9 9 9 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 3 3 4 4 1 1 4 4 1 1 
17 N N 307965G 1 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 3 3 4 4 3 3 4 4 3 3 
18 N N 307965G 2 9 9 9 9 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 3 3 4 4 3 3 4 4 3 3 
19 B K  312875G 1 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 3 3 2 2 3 3 2 2 3 3 2 2 
20 B K  312875G 2 9 9 9 9 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 3 3 2 2 3 3 2 2 3 3 2 2 
   
   
  
 
 
  
 
 
 
